Cardiovascular diseases and the risk of venous thromboembolism: A hospital-based case-control study

Journal of the Chinese Medical Association

Volumn 70, Issue 3, 2007, Pages 103-109

  Yang, Chen Chang ^a,b   Kao, Chih Chin ^b  

^a NATIONAL YANG MING UNIVERSITY   (Taiwan)

^b TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

Author keywords

Cardiovascular disease; Confounding factors; Pulmonary embolism; Venous thrombosis

Indexed keywords

ACETYLSALICYLIC ACID; ANTICOAGULANT AGENT; ANTILIPEMIC AGENT; ESTROGEN; FIBRIC ACID DERIVATIVE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; ORAL CONTRACEPTIVE AGENT;

ADULT; AGE DISTRIBUTION; AGED; ANTICOAGULANT THERAPY; ARTICLE; ATHEROSCLEROSIS; BODY MASS; CARDIOVASCULAR DISEASE; CONFIDENCE INTERVAL; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; HOSPITAL BASED CASE CONTROL STUDY; HOSPITAL PATIENT; HOSPITALIZATION; HUMAN; HYPERLIPIDEMIA; INCIDENCE; MAJOR CLINICAL STUDY; MALE; PATIENT SELECTION; RANDOM SAMPLE; RISK ASSESSMENT; SEX DIFFERENCE; TERTIARY HEALTH CARE; VARICOSIS; VENOUS THROMBOEMBOLISM; VETERAN;

EID: 34247363192     PISSN: 17264901     EISSN: 17287731     Source Type: Journal    
DOI: 10.1016/S1726-4901(09)70339-9     Document Type: Article

References (25)

1. Heir JA, Silverstein MD, Mohr DN, Petterson TM, O'Fallon WM, Melton III LJ. Risk factors for deep vein thrombosis and pulmonary embolism. Arch Intern Med 2000;160:809-15.
2. Kniffin WD, Baron JA, Barrett J, Birkmeyer JD, Anderson FA Jr. The epidemiology of diagnosed pulmonary embolism and deep venous thrombosis in the elderly. Arch Intern Med 1994; 154:861-6.
3. Geerts WH, Pinea GF, Hett JA, Bergqvist D, Lassen MR, Colwell CW, Ray JG. Prevention of venous thromboembolism. The Seventh ACCP Conference on Antithrombotic and Thrombotic Therapy. Chest 2004;126:338S-400S.
4. Bosson JL, Labarere J, Sevestre MA, Belmin J, Beyssier L, Elias A, Franco A, et al. Deep vein thrombosis in elderly patients hospitalized in subacute care facilities: a multicenter cross-sectional study of risk factors, prophylaxis, and prevalence. Arch Intern Med 2003;163:2613-8.
5. Alikhan R, Cohen AT, Combe S, Samama MM, Desjardins L, Eldor A, Janbon C, et al. Risk factors for venous; thromboembolism in hospitalized patients with acute medical illness: analysis of the MEDENOX study. Arch Intern Med 2004;164: 963-8.
6. Black C, Kaye JA, Jick H. Clinical risk factors for venous thromboembolus in users of the combined oral contraceptive pill. Br J Clin Pharmacol 2002;53:637-40.
7. Cushman M, Tsai AW, White RH, Heckbert SR, Rosamond WD, Enright P, Folsom AR. Deep vein thrombosis and pulmonary embolism in two cohorts: the longitudinal investigation of thromboembolism etiology. Am J Med 2004;117:19-25.
8. Zornberg GL, Jick H. Antipsychotic drug use and risk of first-time idiopathic venous thromboembolism: a case-control study. Lancet 2000;356:1219-23.
9. Pérez-Gutthann S, Garcia Rodriguez LA, Castellsague J, Oliart AD. Hormone replacement therapy and risk of venous thromboembolism: population based case-control study. Br Med J 1997; 314:796-800.
10. Yang CC, Jick SS, Jick H. Statins and the risk of idiopathic venous thromboembolism. Br J Clin Pharmacol 2002;53:101-5.
11. Grady D, Wenger NK, Herrington D, Khan S, Furberg C, Hunninghake D, Vittinghoff E, et al. Postmenopausal hormone therapy increases risk for venous thromboembolic disease: the Heart and Estrogen/progestin Replacement Study. Ann Intern Med 2000;132:689-96.
12. Lacut K, Oger E, Le Gal G, Couturaud F, Louis S, Leroyer C, Mottier D. Statins but not fibrates are associated with a reduced risk of vcnous thromboembolism: a hospital-based case-control study. Fundam Clin Pharmacol 2004;18:477-82.
13. Rosenson RS, Tangney CC. Antiatherothrombotic properties of statins: implication for cardiovascular event reduction. JAMA 1998;279:1643-50.
14. Daly E, Vessey MP, Hawkins MM, Carson JL, Gough P, Marsh S. Risk of venous thromboembolism in users of hormone replacement therapy. Lancet 1996;348:977-80.
15. Ray JG, Tsuyuki RT, Anderson DR, Yeo EL, Laupacis A. Use of statins and the subsequent development of deep vein thrombosis. Arch Intern Med 2001;161:1405-10.
16. World Health Organization Collaborative Study of Cardiovascular Disease and Steroid Hormone Contraception. Venous thromboembolic disease and combined oral contraceptives: results of international multicentre case-control study. Lancet 1995;346:1575-82.
17. Cogo A, Bernardi E, Pradoni P, Girolami B, Noventa F, Simioni P, Girolami A. Acquired risk factors for deep-vein thrombosis in symptomatic outpatients. Arch Intern Med 1994; 154: 164-8.
18. Libertiny G, Hands L. Deep venous thrombosis in peripheral vascular disease. Br J Surg 1999;86:907-10.
19. Langhorne P, Stott DJ, Robertson L, MacDonald J, Jones L, McAlpine C, Dick F, et al. Medical complications after stroke: a multicenter study. Stroke 2000;31:1223-9.
20. Kelly J, Rudd A, Lewis RR, Coshall C, Moody A, Hunt BJ. Venous thromboembohsm after acute ischemic stroke: a prospective study using magnetic resonance direct thrombus imaging. Stroke 2004;35:2320-5.
21. Goldman MP, Fronek A. Anatomy and pathophysiology of varicose veins. J Dermatol Surg Oncol 1989;15:138-45.
22. Kurz X, Lamping DL, Kahn SR, Baccaglini U, Zuccarelli F, Spreafico G, Abenhaim L. Do varicose veins affect quality of life? Results of an international population-based study. J Vasc Surg 2001;34:641-8.
23. Decousus H, Epinat M, Guillot K, Quenet S, Boissier C, Tardy B. Superficial vein thrombosis: risk factors, diagnosis, and treatment. Curr Opin Pulm Med 2003;9:393-7.
24. Kawasaki T, Kambayashi JI, Aruyoshi H, Sakon M, Suehisa E, Monden M. Hypercholesterolemia as a risk factor for deep-vein thrombosis. Thromb Res 1997;88:67-73.
25. Vaya A, Mira Y, Martinez M, ViUa P, Ferrando F, Estelles A, Corella D, et al. Biological risk factors for deep vein thrombosis. Clin Hemorheol Microcirc 2002;26:41-53.